Objective:
The aim of this study is to adapt Khalfa Hyperacusis Questionnaire (HQ) into Turkish for the use in the diagnosis and treatment of patients with hyperacusis.
Method:
HQ and Beck Anxiety Inventory (BAI) were administered to a total of 529 participants (320 female, 209 male), aged 18 to 73 (mean age: 29.76±10.59) years who were randomly selected from the general population. For the evaluation of the data, confirmatory and exploratory factor analysis, correlation analysis, descriptive statistics, t-test, analysis of variance, and Sidak correction test were used.
Results:
In the reliability analysis, the Cronbach’s alpha (aC) internal consistency coefficient was found to be 0.81. Factor analysis revealed three subdimensions (attentional, social, and emotional). The total variance of these three subdimensions were 63%, and the internal consistency of the subdimensions was also high (αC >0.70). Confirmatory factor analysis and structural equation modeling results indicated that three-factor solutions with 14 items met the criteria for the adequacy of fit among the Turkish patients. The mean score for hyperacusis was estimated as 15.69±6.63 points.There was a positive, weak, but significant association between hyperacusis and anxiety (r=0.357, p=0.01, p<0.05). The patients who were exposed to noise were found to have higher levels of hyperacusis, compared to those who were not (t=6.78, p=0.01, p<0.05). The patients who had decreased noise tolerance over time were found to be higher hyperacusis levels than those without (t=4.83, p=0.01, p<0.05).
Conclusion
Based on these measurements, 14 questions and three-factor solutions were found to be a valid and reliable tool.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.